跳至主要内容
临床试验/NCT05829044
NCT05829044招募中不适用

Impact of Sex and Age on Non-visual Light Input That Affects Sleep and Circadian Rhythms

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2023年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
48
试验地点
1
主要终点
Melatonin levels for circadian timing assessment

研究概览

简要总结

The goal of this clinical trial is to learn how the pupil responds to different light stimuli and how that relates to sleep and daily rhythms in healthy people of different ages.

The main questions it aims to answer are:

  • Does the eye's pupil response to light stimuli differ by the sex and age of the participant?
  • Is the eye's pupil response to light stimuli related to each participant's sleep timing, their body clock timing, and their hormone responses to light.

Participants will have a special eye exam and complete questionnaires before starting the study to see if they can participate. If they can participate, they will wear a special watch that monitors their activity and light levels for one week. Then they will live in a research room at the Mass General Hospital for 3 days/2 nights during which we will test their pupil response to light, their body clock timing, and their hormone responses to light.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •(i) 18-85 years old.
  • •(ii) Habitual sleep onset 10 pm- 1 am (healthy controls only);
  • •(iii) Habitual wake onset 5:30 am- 8:30 am (healthy controls only);
  • •(iv) vision correctable to 20/30;
  • •(v) stable medically.
  • •(vi) ability to speak, understand, and read English at a high school level

排除标准

  • •(i) Color blind by Ishihara Color Blindness Test;
  • •(ii) any history of eye trauma, surgery or abnormality (e.g., retinopathy, glaucoma, cataracts, amblyopia, macular degeneration, congenital color vision deficiencies, or any type of blindness) besides correctable vision abnormalities (e.g., with glasses); any abnormalities on clinical eye exam (e.g., neuritis, Neuromyelitis optica, treated or untreated glaucoma) such that the ophthalmologist recommends the participant not be studied; Limited cataracts (e.g., Lens Opacities Classification (LOCS) III grade <2) will be allowed and documented during the eye exam. Eye drops that affect pupil size or contractility (e.g. mydriatics, miotics); drops to treat glaucoma (e.g., pilocarpine, brimonidine, other drops like artificial tear drops, or anti-inflammatory drops would not be exclusionary)
  • •(iii) current or history of neurologic or psychiatric disease including autonomic function disorder or migraines; psychiatric disorder requiring medications in a first degree relative (healthy controls only); limited-duration counseling without prescription medications will not be exclusionary; (iv) current or history of circadian rhythm sleep-wake disorder (healthy controls only);
  • •(v) prescription or non-prescription drugs affecting the pupil (e.g., affecting autonomic function), sleep, melatonin (e.g., lithium, alpha- and beta-adrenergic antagonists), and/or circadian rhythms (e.g., beta blockers, non-steroidal anti-inflammatory drugs, tricyclics);
  • •(vi) Other disorders that can affect or may be affected by intrinsically photosensitive Retinal Ganglion Cell (ipRGC) function, including diabetes mellitus, multiple sclerosis, Parkinson's disease, seasonal affective disorder;
  • •(vii) shift- or night-work in past three months; history of night work in preceding 3 year period
  • •(viii) crossing more than 2 time zones in past three months;
  • •(ix) presence of depression as assessed by a Beck Depression Inventory (BDI) score >
  • •(x) pregnant or less than 6 weeks post-partum or breast-feeding

研究组 & 干预措施

Testing non-visual light impacts on pupil response, circadian timing, and hormones

Experimental
  1. Pupillometry on day 1 in afternoon and evening and on day 2 in morning and evening. Participants will be randomized to one of 8 different light stimuli within the pupillometry
  2. Red light exposure on night 1 to determine circadian timing
  3. Blue/green light exposure on night 2 to compare hormone response during blue/green light to that during red light on night 1

干预措施: Pupillometry (Device)

Testing non-visual light impacts on pupil response, circadian timing, and hormones

Experimental
  1. Pupillometry on day 1 in afternoon and evening and on day 2 in morning and evening. Participants will be randomized to one of 8 different light stimuli within the pupillometry
  2. Red light exposure on night 1 to determine circadian timing
  3. Blue/green light exposure on night 2 to compare hormone response during blue/green light to that during red light on night 1

干预措施: Light box exposure (Device)

结局指标

主要结局

Melatonin levels for circadian timing assessment

时间窗: Night 1

Melatonin levels from saliva collection during Night 1 light box red light exposure

Melatonin levels for hormone response

时间窗: Night 1 and Night 2

Melatonin levels from saliva collection during Night 2 light box blue/green light exposure compared to those during Night 1 light box red light exposure

Pupil size

时间窗: During pupillometry testing on Day 1 afternoon, Day 1 evening, Day 2 morning, Day 2 evening

Pupil size as measured by pupillometry

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elizabeth B Klerman MD PhD

Professor

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验